Gemcitabine in Newly-Diagnosed Diffuse Midline Glioma
Clinical trial NCT04051047 · WITHDRAWN
Trial details
- NCT number
- NCT04051047
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- WITHDRAWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-30
- Primary completion
- 2021-12-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.